BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 29055389)

  • 21. Oral cancer cell‑derived exosomes modulate natural killer cell activity by regulating the receptors on these cells.
    Zhu X; Qin X; Wang X; Wang Y; Cao W; Zhang J; Chen W
    Int J Mol Med; 2020 Dec; 46(6):2115-2125. PubMed ID: 33125101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the key communicator role of exosomes in cancer microenvironment through proteomics.
    Kim H; Kim DW; Cho JY
    Proteome Sci; 2019; 17():5. PubMed ID: 31686989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The release of tryptase from mast cells promote tumor cell metastasis via exosomes.
    Xiao H; He M; Xie G; Liu Y; Zhao Y; Ye X; Li X; Zhang M
    BMC Cancer; 2019 Oct; 19(1):1015. PubMed ID: 31664930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sortilin is essential for proNGF-induced neuronal cell death.
    Nykjaer A; Lee R; Teng KK; Jansen P; Madsen P; Nielsen MS; Jacobsen C; Kliemannel M; Schwarz E; Willnow TE; Hempstead BL; Petersen CM
    Nature; 2004 Feb; 427(6977):843-8. PubMed ID: 14985763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [NRH2 induces cell apoptosis of cerebral tissues around hematomas after intracerebral hemorrhage through up-regulating proNGF, sortilin and p75NTR expressions].
    Zeng Z; Liu H; Jiang D
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Apr; 31(4):532-6, 539. PubMed ID: 25854576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular and structural insight into proNGF engagement of p75NTR and sortilin.
    Feng D; Kim T; Ozkan E; Light M; Torkin R; Teng KK; Hempstead BL; Garcia KC
    J Mol Biol; 2010 Mar; 396(4):967-84. PubMed ID: 20036257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ProNGF mediates death of Natural Killer cells through activation of the p75NTR-sortilin complex.
    Rogers ML; Bailey S; Matusica D; Nicholson I; Muyderman H; Pagadala PC; Neet KE; Zola H; Macardle P; Rush RA
    J Neuroimmunol; 2010 Sep; 226(1-2):93-103. PubMed ID: 20547427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ProNGF, but Not NGF, Switches from Neurotrophic to Apoptotic Activity in Response to Reductions in TrkA Receptor Levels.
    Ioannou MS; Fahnestock M
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Could lung cancer exosomes induce apoptosis of natural killer cells through the p75NTR-proNGF-sortilin axis?
    Zhu MC; Xiong P; Li GL; Zhu M
    Med Hypotheses; 2017 Oct; 108():151-153. PubMed ID: 29055389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The proNGF-p75NTR-sortilin signalling complex as new target for the therapeutic treatment of Parkinson's disease.
    Chen LW; Yung KK; Chan YS; Shum DK; Bolam JP
    CNS Neurol Disord Drug Targets; 2008 Dec; 7(6):512-23. PubMed ID: 19128208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NGF and ProNGF: Regulation of neuronal and neoplastic responses through receptor signaling.
    Bradshaw RA; Pundavela J; Biarc J; Chalkley RJ; Burlingame AL; Hondermarck H
    Adv Biol Regul; 2015 May; 58():16-27. PubMed ID: 25491371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ProNGF, sortilin, and age-related neurodegeneration.
    Al-Shawi R; Hafner A; Chun S; Raza S; Crutcher K; Thrasivoulou C; Simons P; Cowen T
    Ann N Y Acad Sci; 2007 Nov; 1119():208-15. PubMed ID: 18056969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Balancing neurotrophin pathway and sortilin function: Its role in human disease.
    Al-Yozbaki M; Acha-Sagredo A; George A; Liloglou T; Wilson CM
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188429. PubMed ID: 32956766
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.